Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib.
Saved in:
| Title: | Insights from a rare myeloproliferative neoplasm with coexisting BCR‐ABL1 fusion gene, CALR, and TET2 mutations treated with nilotinib and ruxolitinib. |
|---|---|
| Authors: | Huo, Li1 (AUTHOR), Xie, Jundan1 (AUTHOR), Wang, Qian1 (AUTHOR), Shen, Hongjie1 (AUTHOR), Ding, Zixuan1 (AUTHOR), Wen, Lijun1 (AUTHOR), Zeng, Zhao1 (AUTHOR), Xu, Yi1 (AUTHOR), Ruan, Changgeng1,2 (AUTHOR), Chen, Suning1,2 (AUTHOR) chensuning@suda.edu.cn, Xue, Mengxing1 (AUTHOR) xuemengxing@suda.edu.cn |
| Source: | Clinical Case Reports. Jan2023, Vol. 11 Issue 1, p1-7. 7p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 20500904 |
|---|---|
| DOI: | 10.1002/ccr3.6801 |
